Taking into consideration the dynamic nature of the National Medicines Verification System (NMVS) versions, meant to improve the overall system’s performance, the need to update the interfaces used by the End-Users (EU) to connect to the NMVS comes as a logical consequence.

Thus, the V3 interface version used by the software providers to connect the software used by the End-Users to the NMVS will be disconnected in April 2022, when the V5 version will be released.

We kindly ask all software providers to migrate as soon as possible to the V4 interface version, using the documentation provided by Arvato in the portal: https://www.sws-nmvs.eu.